Feb 09, 2018
395:344
For every 344 shares held, investors received 395. The price per share adjusted from $15.80 to $13.76.
The split itself did not change the total investment value.
Huaren Pharmaceutical Co., Ltd. Class A (SZSE:300110) operates in the Medical specialties industry.
Huaren Pharmaceutical Co., Ltd. Class A company overviewHuaren Pharmaceutical Co., Ltd. Class A's most recent stock split was on February 9, 2018. It was a 395-for-344 forward split, so shareholders received 395 shares for every 344 they held.
Huaren Pharmaceutical Co., Ltd. Class A (SZSE:300110) has split its stock 4 times: a 2-for-1 split on May 16, 2013, a 3-for-2 split on May 7, 2014, a 33-for-20 split on May 31, 2017, and a 395-for-344 split on February 9, 2018.
Huaren Pharmaceutical Co., Ltd. Class A has split its stock 4 times. This history records 4 forward splits between May 16, 2013 and February 9, 2018.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Huaren Pharmaceutical Co., Ltd. Class A's 395-for-344 split on February 9, 2018, every 344 shares became 395 shares.
Huaren Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on February 9, 2018, 8 years ago. Companies announce splits in advance, and any new SZSE:300110 split will appear on this page.
Already premium?